ED
NGLS

Exane Derivatives’s TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT NGLS Stock Holding History

Exane Derivatives’s Portfolio NGLS Stock Details NGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-28
Closed -$463 – 627
2015
Q4 		$463 Hold
28
– – ﹤0.01% 420
2015
Q3 		$813 Buy
28
+3
+12% +$101 ﹤0.01% 441
2015
Q2 		$965 Hold
25
– – ﹤0.01% 445
2015
Q1 		$1.03K Sell
25
-171
-87% -$7.5K ﹤0.01% 447
2014
Q4 		$9.38K Buy
+196
New +$11.1K ﹤0.01% 417

Other funds holding NGLS

FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return
WPEP
Walnut Private Equity Partners Omaha, Nebraska $185M AUM 6.42% 1-Year Est. Return
TCM
Texan Capital Management Houston, Texas $154M AUM 10.81% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Exane Derivatives's NGLS Position: Q1 2016 in Review

Exane Derivatives sold out of TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT (NGLS) in Q1 2016, closing a stake of 28 shares — an estimated $463 sold.

Exane Derivatives first reported a position in NGLS in Q4 2014 and held it in 5 quarters. The position peaked at $9.38K in Q4 2014. 5 funds tracked by Wall St. Rank hold NGLS as of Q1 2016.

  • Exane Derivatives reported no remaining TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT position as of Q1 2016 after selling out during the quarter.
  • Exane Derivatives sold 28 TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT shares in Q1 2016, an estimated $463.
  • Exane Derivatives first reported a position in TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT in Q4 2014 and held it in 5 quarters.
  • Exane Derivatives's TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT position peaked at $9.38K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT as of Q1 2016.

Based on Exane Derivatives's 13F filing for Q1 2016, filed 4 May 2016.